 | Mesoblast Limited | |||
| NMS : MESO || Location: Australia | ||||
$6.15-0.07 (-1.13%) |
0.24 M | 5.9 - 6.28 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.716 M |
| March 28, 2024 | 2.342 M |
| March 15, 2024 | 0.507 M |
| Feb. 29, 2024 | 0.507 M |
| Feb. 15, 2024 | 0.543 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2023 | -0.13 | -0.03 | 78.79% |
| 03/31/2023 | -0.05 | -0.02 | 50.52% |
| 12/31/2022 | -0.06 | -0.03 | 48.11% |
| 09/30/2022 | -0.05 | -0.02 | 52.51% |
| 06/30/2022 | -0.10 | -0.17 | -70.00% |
MESO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 114.071M | Shares Float | 114.071M |
| Short Float | 0.716M | Market Cap | 709.52M |
| Institution ownership | 0.72% | Insider ownership | 0.000% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -0.87 | Forward EPS | -0.78 |